3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
36
OTHER_GOV
2
INDUSTRY
2
NETWORK
1
FED
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Pancreatic adenoma
2
Pancreatic Neoplasms
2
Pancreatic Cyst
2
Lymphadenopathy
2
Cysts
2
Arachnodactyly
2
Adenoma, Islet Cell
2
Interventions
Gemcitabine
302
Fluorouracil
296
Oxaliplatin
269
Bevacizumab
267
Capecitabine
233
Leucovorin
229
pembrolizumab
215
Irinotecan
185
Cisplatin
142
Cetuximab
142
Nivolumab
131
Paclitaxel
117
130-nm albumin-bound paclitaxel
117
Sorafenib
86
Albumin-Bound Paclitaxel
75
Docetaxel
65
regorafenib
64
atezolizumab
64
IFL protocol
61
Folfox protocol
61
Trastuzumab
54
Panitumumab
47
durvalumab
46
Ramucirumab
43
Injections
43
Sunitinib
41
Drug Therapy
41
Carboplatin
40
trifluridine tipiracil drug combination
38
lenvatinib
38
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Endoscopic Ultrasound-Guided Fine Needle Aspiration
×
Gastrointestinal
×
Clear all
NCT01563133
2017-08-29
CONTACT
Mauna Kea Technologies
Phase NA
Unknown
330 enrolled
NCT01770405
2017-08-29
US-nCLE
Mauna Kea Technologies
Completed
40 enrolled